Skip to main content
Egyptian Liver Journal
Fig. 1 | Egyptian Liver Journal

Fig. 1

From: Baseline and recurrent exposure to the standard dose of artemisinin-based combination therapies (ACTs) induces oxidative stress and liver damage in mice (BALB/c)

Fig. 1

(A) Plasma Malondialdehyde (MDA) concentration, (B) Liver Malondialdehyde (MDA) concentration, (C) Plasma Glutathione (GSH) concentration, (D) Liver Glutathione (GSH) concentration of mice after the 1st, 2nd 3rd, and 6th treatment with artemether/lumefantrine (A/L) or artesunate/amodiaquine (A/A). Values are expressed as mean ± SEM (n = 3), and a, b, and c indicate significant differences at p < 0.05, p < 0.01, and p < 0.001, respectively, compared to the corresponding control groups

Back to article page